Welcome to the EPA 2021 Interactive Programme

The congress will officially run on Central European Time (CEST)

To convert the congress times to your local time Click Here

 Fully Live with Live Q&A  On Demand with Live Q&A   ECP Session   Section Session   EPA Course (Pre-Registration Required)   
 

                 

Displaying One Session

Industry Session
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 3
Chair(s)
  • A. Szulc, Poland
Session Description
The horizon in treatment of schizophrenia: from the onset to the chronic stage - SUPPORTED BY Richter-Recordati

Session Description

The symposium aims to address the broad-spectrum treatment of schizophrenia using the clinical staging framework. In the first lecture the role of partial dopamine agonists in the first episode of psychosis will be uncovered utilizing cariprazine, a third-generation antipsychotic medication as an example. Then, the second lecture will focus on the three R’s in the middle stage of schizophrenia: relapse, remission and recovery, and explain how cariprazine data from clinical trials are linked to these concepts. The final lecture will detail the treatment goals and options in the chronic stage of schizophrenia with special attention to the neurocognitive and negative symptoms and their connection to quality of life and everyday functioning

Session Icon
Pre-Recorded with Live Q&A
Industry Session not Included in the Main Event CME / CPD Credit (ID 1116) No Topic Needed

The horizon in treatment of schizophrenia: from the onset to the chronic stage

Session Icon
Pre-Recorded with Live Q&A
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 3
Lecture Time
19:00 - 19:00
Industry Session not Included in the Main Event CME / CPD Credit (ID 1116) No Topic Needed

Supported by Richter-Recordati

Session Icon
Pre-Recorded with Live Q&A
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 3
Lecture Time
19:00 - 19:00
Industry Session not Included in the Main Event CME / CPD Credit (ID 1116) No Topic Needed

Welcome & Introduction

Session Icon
Pre-Recorded with Live Q&A
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 3
Lecture Time
19:00 - 19:05
Presenter
  • A. Szulc, Poland
Industry Session not Included in the Main Event CME / CPD Credit (ID 1116) No Topic Needed

The role of partial dopamine agonists at the dawn of psychosis

Session Icon
Pre-Recorded with Live Q&A
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 3
Lecture Time
19:05 - 19:30
Presenter
  • S. Stahl, United States of America
Industry Session not Included in the Main Event CME / CPD Credit (ID 1116) No Topic Needed

Cariprazine and the three R’s: relapse, remission and recovery

Session Icon
Pre-Recorded with Live Q&A
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 3
Lecture Time
19:30 - 19:55
Presenter
  • S. Leucht, Germany
Industry Session not Included in the Main Event CME / CPD Credit (ID 1116) No Topic Needed

Finding the light in the night: late stage treatment of schizophrenia

Session Icon
Pre-Recorded with Live Q&A
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 3
Lecture Time
19:55 - 20:20
Presenter
  • P. Falkai, Germany
Industry Session not Included in the Main Event CME / CPD Credit (ID 1116) No Topic Needed

Live Q&A

Session Icon
Pre-Recorded with Live Q&A
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 3
Lecture Time
20:20 - 20:30
Presenter
  • S. Stahl, United States of America
  • S. Leucht, Germany
  • P. Falkai, Germany
  • A. Szulc, Poland